{
  "id": 3292,
  "text": "1235.Lin, S.Y., et al.The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.Int J Radiat Oncol Biol Phys 92, 577-585 (2015).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1235.Lin, S.Y., et al.The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.Int J Radiat Oncol Biol Phys 92, 577-585 (2015).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "术前FDG-PET在治疗伴有盆腔淋巴结肿大的宫颈癌患者时，能够提供关键的代谢影像信息，有助于更准确地评估肿瘤及转移淋巴结的范围和活性。与单纯依赖MRI相比，FDG-PET在确定转移性疾病的分布、尤其是远处转移时具有更高的敏感性。这种优势有助于优化治疗方案，例如决定是否需要在手术前采取更积极的化疗或放疗策略，从而提高疗效并降低术后复发风险。\n\n根据长期随访研究，术前使用FDG-PET指导治疗决策可以显著改善部分患者的预后，因为它能够帮助识别出那些可能获益于调节治疗策略的高风险亚组患者。因此，FDG-PET是一种在宫颈癌个体化治疗中具有重要意义的工具。",
  "query": "在治疗伴有盆腔淋巴结肿大的宫颈癌患者时，术前FDG-PET在优化治疗决策中发挥了什么作用？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在治疗伴有盆腔淋巴结肿大的宫颈癌患者时，术前FDG-PET在优化治疗决策中发挥了什么作用？\n\n<reference text>: 1235.Lin, S.Y., et al.The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.Int J Radiat Oncol Biol Phys 92, 577-585 (2015).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "术前FDG-PET在治疗伴有盆腔淋巴结肿大的宫颈癌患者时，能够提供关键的代谢影像信息，有助于更准确地评估肿瘤及转移淋巴结的范围和活性。与单纯依赖MRI相比，FDG-PET在确定转移性疾病的分布、尤其是远处转移时具有更高的敏感性。这种优势有助于优化治疗方案，例如决定是否需要在手术前采取更积极的化疗或放疗策略，从而提高疗效并降低术后复发风险。\n\n根据长期随访研究，术前使用FDG-PET指导治疗决策可以显著改善部分患者的预后，因为它能够帮助识别出那些可能获益于调节治疗策略的高风险亚组患者。因此，FDG-PET是一种在宫颈癌个体化治疗中具有重要意义的工具。"
}